Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 4th December 2012
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Lymphoma patients needed for trial
Six months of free remission monitoring to aid study

Axiom Veterinary Laboratories are looking for dogs that have been diagnosed with lymphoma in order to validate a test.

The test has been developed by Petscreen, to find acute phase proteins for monitoring remission in canine lymphoma patients.

Axiom will be performing a trial of Petscreen's work, to assess its ability to detect when a lymphoma patient is in and out of remission. If validated, vets old be provided with a method of identifying relapse earlier than palpation alone, which could potentially extend patient's lives.

To be involved in the trial, Axiom are looking for dogs that have cytologically or histologically confirmed lymphoma, diagnosed within two weeks of the first serum sample being taken. Preferably, they would not have received any treatment, including steroids.

The process will involve testing a serum sample taken from the patient at week zero, followed by monthly tests to monitor the patient's status, therefore, offering 100 patients six months of free remission monitoring.

If you would like a discussion, or have any patients you would like to put forward for the trial, please contact Emma Dewhurst of Axiom on 01626 355655 or via email.

Click here to find out more about Petscreen's work on the development so far.

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
RCVS annual renewal fee for vets due

RCVS' annual renewal fee for veterinary surgeons is now due. Vets must pay their renewal fee before Wednesday, 1 April 2026.

This year's standard annual fee has increased to 431 from last year's 418. This is an approximately three per cent increase, as approved by RCVS Council and the Privy Council.

Tshidi Gardner, RCVS treasurer, said: "The small fee increase will be used to help deliver both our everyday activities and our new ambitious Strategic Plan, which includes aims such as achieving new legislation, reviewing the Codes of Professional Conduct and supporting guidance, and continuing to support the professions through activities such as the Mind Matters Initiative, RCVS Academy and career development."

A full breakdown of the new fees is on the RCVS website. Information about tax relief is available on the UK government website.